CA2086914A1 - Quinolone-and naphthyridone-carboxylic acid derivatives - Google Patents

Quinolone-and naphthyridone-carboxylic acid derivatives

Info

Publication number
CA2086914A1
CA2086914A1 CA002086914A CA2086914A CA2086914A1 CA 2086914 A1 CA2086914 A1 CA 2086914A1 CA 002086914 A CA002086914 A CA 002086914A CA 2086914 A CA2086914 A CA 2086914A CA 2086914 A1 CA2086914 A1 CA 2086914A1
Authority
CA
Canada
Prior art keywords
carboxylic acid
acid derivatives
naphthyridone
quinolone
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002086914A
Other languages
French (fr)
Other versions
CA2086914C (en
Inventor
Uwe Petersen
Andreas Krebs
Thomas Schenke
Thomas Philipps
Klaus Grohe
Klaus-Dieter Bremm
Rainer Endermann
Karl-Georg Metzger
Ingo Haller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27203290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2086914(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4200414A external-priority patent/DE4200414A1/en
Priority claimed from DE4208789A external-priority patent/DE4208789A1/en
Priority claimed from DE4208792A external-priority patent/DE4208792A1/en
Application filed by Bayer AG filed Critical Bayer AG
Priority to CA002443307A priority Critical patent/CA2443307C/en
Publication of CA2086914A1 publication Critical patent/CA2086914A1/en
Application granted granted Critical
Publication of CA2086914C publication Critical patent/CA2086914C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Abstract

The invention relates to new quinolone- and naphthyridone carboxylic acid derivatives, processes for their preparation and also antibacterial agents and feed additives containing them.
CA002086914A 1992-01-10 1993-01-07 Quinolone-and naphthyridone-carboxylic acid derivatives Expired - Lifetime CA2086914C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002443307A CA2443307C (en) 1992-01-10 1993-01-07 Quinolone- and naphthyridone-carboxylic acid derivatives

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4200414A DE4200414A1 (en) 1992-01-10 1992-01-10 New quinoline and naphthyridinone-carboxylic acid derivs.
DEP4200414.4 1992-01-10
DE4208789A DE4208789A1 (en) 1992-03-19 1992-03-19 New quinoline and naphthyridinone-carboxylic acid derivs.
DEP4208789.9 1992-03-19
DEP4208792.9 1992-03-19
DE4208792A DE4208792A1 (en) 1992-03-19 1992-03-19 New quinoline and naphthyridinone-carboxylic acid derivs.

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002443307A Division CA2443307C (en) 1992-01-10 1993-01-07 Quinolone- and naphthyridone-carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
CA2086914A1 true CA2086914A1 (en) 1993-07-11
CA2086914C CA2086914C (en) 2005-03-15

Family

ID=27203290

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002086914A Expired - Lifetime CA2086914C (en) 1992-01-10 1993-01-07 Quinolone-and naphthyridone-carboxylic acid derivatives

Country Status (16)

Country Link
EP (1) EP0550903A1 (en)
JP (3) JPH05271229A (en)
KR (1) KR100251886B1 (en)
CN (3) CN1043142C (en)
AU (1) AU669502B2 (en)
CA (1) CA2086914C (en)
CZ (1) CZ289076B6 (en)
FI (3) FI104174B1 (en)
HU (1) HU219488B (en)
MX (1) MX9207604A (en)
MY (1) MY115416A (en)
NO (1) NO301420B1 (en)
NZ (1) NZ245640A (en)
PL (1) PL174853B1 (en)
SK (3) SK285155B6 (en)
TW (1) TW209865B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6392044B1 (en) 1999-07-06 2002-05-21 Bayer Aktiengesellschaft Racemization of R,S-dioxo-benzylpyrrolopiperidine
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6566523B1 (en) 1999-06-16 2003-05-20 Bayer Aktiengesellschaft Method for the enantiomer separation of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6897315B2 (en) 1997-11-24 2005-05-24 Bayer Healthcare Aktiengesellschaft Method for producing 8-methoxy-quinolinecarboxylic acids
US7759362B2 (en) 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
US8975275B2 (en) 1999-12-22 2015-03-10 Bayer Innovation Gmbh Use of chemotherapeutic agents

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04445A (en) 1990-04-17 1992-01-06 Fuji Photo Film Co Ltd Processing method for silver halide color photosensitive material
DE69127130T2 (en) 1990-05-09 1997-12-11 Fuji Photo Film Co Ltd Photographic processing composition and processing method using the same
DE4121214A1 (en) * 1991-06-27 1993-01-14 Bayer Ag 7-AZAISOINDOLINYL CHINOLONE AND NAPHTHYRIDONE CARBONIC ACID DERIVATIVES
NO301165B1 (en) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicyclic amine derivatives and antibacterial agents containing them
KR0148277B1 (en) * 1993-01-18 1998-11-02 채영복 Novel fluoroquinolone derivatives and process for the preparation thereof
DE4301246A1 (en) * 1993-01-19 1994-07-21 Bayer Ag Quinolone and naphthyridonecarboxylic acid derivatives
JP3372994B2 (en) 1993-06-11 2003-02-04 富士写真フイルム株式会社 Processing method of silver halide color photographic light-sensitive material
DE4329600A1 (en) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d, e] [1,3,4] benzoxadiazine derivatives
KR950018003A (en) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 Novel quinolone derivatives and methods for their preparation
DE4342186A1 (en) * 1993-12-10 1995-06-14 Bayer Ag One-pot process for the production of 3-quinolonecarboxylic acid derivatives
DE4418510A1 (en) * 1994-05-27 1995-11-30 Bayer Ag 1,9-bridged thiazolol [3,4-a] quinoline derivatives
AU6221296A (en) * 1995-06-07 1996-12-30 Bayer Aktiengesellschaft Testing device for determining the susceptibility of microor ganisms to inhibitory agents
DE19546249A1 (en) * 1995-12-12 1997-06-19 Bayer Ag New crystal modification of 1-cyclopropyl-7 - ([S, S] -2,8-diazabicyclo [4,3,0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4 -oxo-3-quinoline carboxylic acid hydrochloride (CDCH), process for its preparation and pharmaceutical preparations containing it
DE19652239A1 (en) * 1996-12-16 1998-06-18 Bayer Ag Use of 7- (2-oxa-5,8-diazabicyclo [4.3.0] non-8-yl) -quinolone and naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and the associated gastroduodenal diseases
DE19735198A1 (en) * 1997-08-14 1999-02-18 Bayer Ag Optical resolution of cis- or trans-pyrrolo:piperidine derivatives
NZ503538A (en) * 1997-09-25 2001-03-30 Bayer Ag Moxifloxacin formulation characterised by the release times containing hydroxypropylmethylcellulose or polyvinylpyrrolidone as binder and ethylcellulose as film forming polymer
DE19821039A1 (en) * 1998-05-11 1999-11-18 Bayer Ag Production of (S,S)-8-benzyl-2,8-diazabicyclo(4.3.0)nonane useful as intermediate for antibiotic moxifloxacin
AR020661A1 (en) * 1998-09-30 2002-05-22 Alcon Lab Inc A PHARMACEUTICAL COMPOSITION TOPICA OFTALMICA, OTICA OR NASAL AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
CZ292069B6 (en) * 1998-11-10 2003-07-16 Bayer Aktiengesellschaft Pharmaceutical preparation containing moxifloxacin, process of its preparation and use
EP2275141A1 (en) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
DE10226923A1 (en) 2002-06-17 2003-12-24 Bayer Ag Process for the enantiomer enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0] nonane
ITMI20032259A1 (en) 2003-11-20 2005-05-21 Chemi Spa NEW POLYMORPHOUS OF ACID 1-CYCLOPROPYL-7- (S, S-2,8-DIAZABICLO-4.3.0-NON-8-IL) -6-FLUORO-1,4-DIIDRO-8-METOSSI-4-OXO -CHINOLIN CARBOSXYL CHLORIDRATE AND METHODS FOR ITS PREPARATION
WO2005054240A1 (en) * 2003-11-20 2005-06-16 Chemi Spa Polymorphs of 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
CN1244582C (en) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 Compound of quinolone carboxylic acid, preparation method and medicinal usage
ES2284380B1 (en) * 2006-03-10 2008-11-01 Quimica Sintetica S.A. PROCEDURE FOR THE PREPARATION OF MOXIFLOXACINO AND MOXIFLOXACINO CHLORHYDRATE.
ES2335369T3 (en) 2006-06-27 2010-03-25 Sandoz Ag NEW METHOD FOR THE PREPARATION OF SALTS.
CA2669427A1 (en) 2006-11-13 2008-05-22 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
WO2008059521A2 (en) * 2006-11-14 2008-05-22 Msn Laboratories Limited Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
US7692015B2 (en) 2007-01-05 2010-04-06 Zheqing Wang Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
WO2008102188A1 (en) 2007-02-22 2008-08-28 Tibor Nagy Procedure to manufacture and use beer and other types liquids treated with neodimium magnet
EP2083010A1 (en) 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
IT1393337B1 (en) * 2009-03-06 2012-04-20 Italiana Sint Spa SUMMARY OF (4AS, 7AS) -OTTAIDRO-1H-PIRROLO [3,4-B] PYRIDINE
EP2423211B1 (en) * 2009-04-20 2014-04-16 Kaneka Corporation Processes for producing (1s,6s)- or (1r,6r)-cis-2,8-diazabicyclo[4.3.0]nonane and intermediate thereof
IT1398952B1 (en) * 2010-03-19 2013-03-28 F S I Fabbrica Italiana Sint PROCESS OF PREPARATION OF MOXIFLOXACINE AND ITS SALTS
CN101941969B (en) * 2010-09-30 2012-05-23 江苏正大丰海制药有限公司 Preparation method of moxifloxacin hydrochloride
CN102675307A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing chiral compound 8-phenethyl-2,8-diazabicyclo[4.3.0]nonane
CN102675308A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing 8-benzyl-2,8-diazabicyclo(4.3.0) nonane
ITTO20110705A1 (en) 2011-07-29 2013-01-30 Italiana Sint Spa PROCEDURE FOR THE PREPARATION OF MOXIFLOXACINE CHLORIDRATE AND RELATED INTERMEDIATES
CN102964346B (en) * 2011-09-01 2015-04-22 中国中化股份有限公司 Preparation method of (S, S)-octahydro-6H-pyrrolo[3, 4-b]pyridine
CN103044418B (en) * 2011-10-14 2015-02-04 上海朴颐化学科技有限公司 Asymmetric synthesis method, relevant raw materials and preparation method of (S,S)-2,8-diazabicyclo[4,3,0] nonane
CN102408427B (en) * 2011-10-22 2012-12-12 浙江普洛康裕制药有限公司 Preparation method for moxifloxacin intermediate (1S, 6R)-8-benzyl-7, 9-dioxy-2, 8-diazabicyclo [4.3.0] nonane
BRPI1106900A2 (en) 2011-12-26 2013-11-05 Ems Sa SOLID PHARMACEUTICAL COMPOSITION UNDERSTANDING ANTIBOTH FAMILY OF QUINOLONES AND THE PROCESS OF OBTAINING THEM
FR2992218B1 (en) 2012-06-22 2015-01-23 Rivopharm Sa PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN HYDROCHLORIDE AND PROCESS FOR PREPARING THE SAME
CA2893534A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
CN103012452B (en) * 2012-12-25 2015-12-02 浙江新和成股份有限公司 The preparation method of a kind of Moxifloxacin and hydrochloride thereof
UA106556C2 (en) * 2013-05-13 2014-09-10 Наталья Николаевна Деркач Method of obtaining (1-cyclopropyl -6- fluoro-1,4-dihydro methoxy -8 -7 - [(4as, 7as) - oktahydro -6n- pyrrolo [3,4-pyridine bsch - 6- yl] -4-oxo-3-hinolinkarbonovoyi acid
CN103724262B (en) * 2013-12-10 2016-05-18 广东省第二人民医院 A kind of fluoquinolone silver compound and its production and use
CN104860944A (en) * 2015-06-09 2015-08-26 内蒙古东北六药集团有限公司 Production method of moxifloxacin hydrochloride
CN108872413B (en) * 2018-04-27 2021-06-08 山东齐都药业有限公司 Method for detecting enantiomer content in (S, S) -2, 8-diazabicyclo [4,3,0] nonane
CN110627768B (en) * 2018-06-22 2021-11-09 扬子江药业集团有限公司 Preparation method of moxifloxacin degradation impurity J
CN110183445B (en) * 2019-06-28 2021-08-24 昆明学院 Synthetic method of moxifloxacin and derivatives thereof
RU2713932C1 (en) * 2019-10-31 2020-02-11 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Fluoroquinolone compounds based on pyridoxine derivatives, having antibacterial properties
CN112939849B (en) * 2019-12-11 2022-05-03 浙江新和成股份有限公司 (S, S) -2, 8-diazabicyclo [4.3.0] nonane intermediate and preparation method and application thereof
CN110981874A (en) * 2020-03-05 2020-04-10 北京四环生物制药有限公司 Preparation method of moxifloxacin hydrochloride
CN112409352B (en) * 2020-11-20 2022-05-24 华南理工大学 Moxifloxacin drug derivatives and preparation method and application thereof
CN112574197B (en) * 2020-12-07 2021-12-31 泰安汉威集团有限公司 Chiral purification method of compound C

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0754229B2 (en) * 1987-09-28 1995-06-07 松下冷機株式会社 refrigerator
DE3906365A1 (en) * 1988-07-15 1990-01-18 Bayer Ag 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM
AU5123690A (en) * 1989-03-13 1990-09-13 Bristol-Myers Squibb Company 5-substituted-1,4-dihydro-4-oxo-nephthyridine-3-carboxylate antibacterial agents
DE3910663A1 (en) * 1989-04-03 1990-10-04 Bayer Ag 5-ALKYLCHINOLON CARBONIC ACIDS
JPH03188080A (en) * 1989-12-15 1991-08-16 Banyu Pharmaceut Co Ltd Pyridonecarboxylic acid derivative

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897315B2 (en) 1997-11-24 2005-05-24 Bayer Healthcare Aktiengesellschaft Method for producing 8-methoxy-quinolinecarboxylic acids
US7115744B2 (en) 1997-11-24 2006-10-03 Bayer Healthcare Aktiengesellschaft Method for producing 8-methoxy-quinolinecarboxylic acids
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US7671070B2 (en) 1998-09-30 2010-03-02 Alcon, Inc. Method of treating ophthalmic infections with moxifloxacin compositions
US8673902B2 (en) 1998-09-30 2014-03-18 Alcon Pharmaceuticals, Ltd. Method of treating otic infections with moxifloxacin compositions
US8993636B2 (en) 1998-09-30 2015-03-31 Alcon Pharamceuticals, Ltd. Compositions containing moxifloxacin for treating otic infections
US6566523B1 (en) 1999-06-16 2003-05-20 Bayer Aktiengesellschaft Method for the enantiomer separation of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane
US6392044B1 (en) 1999-07-06 2002-05-21 Bayer Aktiengesellschaft Racemization of R,S-dioxo-benzylpyrrolopiperidine
US8975275B2 (en) 1999-12-22 2015-03-10 Bayer Innovation Gmbh Use of chemotherapeutic agents
US7759362B2 (en) 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof

Also Published As

Publication number Publication date
FI104174B (en) 1999-11-30
NZ245640A (en) 1995-03-28
JPH05271229A (en) 1993-10-19
SK285223B6 (en) 2006-09-07
SK282971B6 (en) 2003-01-09
CN1043142C (en) 1999-04-28
FI20020059A (en) 2002-01-11
CN1074218A (en) 1993-07-14
SK285155B6 (en) 2006-07-07
FI990207A (en) 1999-02-03
FI104174B1 (en) 1999-11-30
SK2232000A3 (en) 2006-05-04
JP2003026574A (en) 2003-01-29
NO924978L (en) 1993-07-12
CN1192440A (en) 1998-09-09
SK396692A3 (en) 2002-09-10
CN1061351C (en) 2001-01-31
FI930049A0 (en) 1993-01-07
EP0550903A1 (en) 1993-07-14
TW209865B (en) 1993-07-21
MX9207604A (en) 1993-10-01
KR930016421A (en) 1993-08-26
FI930049A (en) 1993-07-11
CN1075499C (en) 2001-11-28
JP4111431B2 (en) 2008-07-02
AU3105493A (en) 1993-07-15
PL174853B1 (en) 1998-09-30
AU669502B2 (en) 1996-06-13
FI990207A0 (en) 1999-02-03
FI113771B (en) 2004-06-15
JP2003048890A (en) 2003-02-21
KR100251886B1 (en) 2000-07-01
MY115416A (en) 2003-06-30
HUT64065A (en) 1993-11-29
CZ396692A3 (en) 1993-08-11
SK2212000A3 (en) 2006-05-04
HU9300034D0 (en) 1993-04-28
NO924978D0 (en) 1992-12-22
NO301420B1 (en) 1997-10-27
CA2086914C (en) 2005-03-15
CN1212256A (en) 1999-03-31
HU219488B (en) 2001-04-28
PL297338A1 (en) 1993-09-06
CZ289076B6 (en) 2001-10-17
FI110943B (en) 2003-04-30

Similar Documents

Publication Publication Date Title
CA2086914A1 (en) Quinolone-and naphthyridone-carboxylic acid derivatives
IL107221A0 (en) Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation
IL102288A0 (en) 7-azaisoindolinyl-quinolone-and naphthyridonecarboxylic acid derivatives,their preparation and antibacterial agents and feed additives containing them
AU3261193A (en) Amino acid derivatives as paf-receptor antagonists
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU3363993A (en) Amino acid derivatives as PAF antagonists
EP0600413A3 (en) Neuro endoscope for shunt.
IL107956A0 (en) Carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
AU4302993A (en) 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxy lic acid compounds and related compounds as antibacterial agents
AU1966392A (en) 8-vinyl- and 8-ethinyl-quinolone-carboxylic acids
CA2097044A1 (en) Cyclopentane- and -pentene-.beta.-amino acids
AU4231293A (en) Substituted pyrido(1,2-A)pyrimidinone derivatives as fungicides
AU1122688A (en) Substituted 3,4-dihydro-2h-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds
CA2064373A1 (en) Piperidine derivatives
DK0481274T3 (en)
AU623688B2 (en) Substituted 1,4-dihydro-4-oxo-1-pyrodinyl- (quinoline or naphthyridine) derivatives
AU537475B2 (en) Z-amino-8-cyclopropyl-5-oxo-5,8-dihydro-pyrido (2,3-d)- pyrimidine-6-carboxylic acid compounds
EP0226842A3 (en) Substituted 1,4-naphthalenediones, processes for their preparation and pharmaceutical compositions containing them
AU5220893A (en) Substituted N-hydroxycinnamamides, processes for their preparation, compositions containing them, and their use
AU564961B2 (en) Bicyclo (3.2.1) octane carboxylic acid derivatives
EP0589318A3 (en)
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PT83141A (en) Process for the preparation of 3,7-disubstituted-3-cephem compounds useful as antimicrobial agents
CA2008766A1 (en) Exo-3',4'-0-benzylidene-3"-demethylchartreusin and its salts
AU5066693A (en) Process for the preparation of 5,6-diacetoxyindole

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20130107